Vertex Pharmaceuticals Incorporated (VRTX)
Market Closed
6 Oct, 08:00 PM
$
502. 31
-1.19
-0.2363%
$
133.69B Market Cap
30.83 P/E Ratio
- Div Yield
775,000 Volume
14.94 Eps
$ 503.5
Previous Close 
Want to track VRTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vertex Pharmaceuticals Incorporated (VRTX) Statistics
Valuation metrics
Market Cap 133.69B
Enterprise value 123.94B
Trailing P/E (ttm) 29.14
Forward P/E 19.95
PEG ratio 1.3
Price/Sales (ttm) 10.15
Price/Book (mrq) 6.33
Enterprise Value/Revenue 9.82
Enterprise Value/EBITDA 22.76
Overview
Shares outstanding 254.16M
Float 253.02M
Shares short 4.17M
% Held by insiders 0%
% Held by institutions 0.98%
Average volume (10 days) 966.03K
Average volume (90 days) 1.29M
Price summary
52-Week low 400.74
52-Week high 560.25
Beta 0.3
50-Day moving average 519.43
200-Day moving average 461.23
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 24 Aug 2000
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.35%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.23%
Income Statement
Revenue (ttm) 12.22B
Revenue per share (ttm) 49.72
Quarterly revenue growth (yoy) 0.08%
Gross profit (ttm) 6.65B
EBITDA 5.26B
Net income to common (ttm) 4.34B
Diluted EPS (ttm) 17.35
Quarterly earnings growth (yoy) 0.6%
Balance Sheet
Total cash (mrq) 7.25B
Total cash per share (mrq) 30.93
Total debt (mrq) 1.99B
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.19%
Book value per share (mrq) 79.75
Cash Flow
Cash flow statement 4.24B
Levered free cash flow (LFCF) 2.78B
2026 © Marketlog. All Rights Reserved.
